Human Papillomavirus-Associated Subsequent Malignancies among Long-Term Survivors of Pediatric and Young Adult Cancers

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Ojha, Rohit P ^a   Tota, Joseph E ^b   Offutt Powell, Tabatha N ^c   Klosky, James L ^a   Minniear, Timothy D ^a   Jackson, Bradford E ^d   Gurney, James G ^a,e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c Delaware Health and Social Services   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF MEMPHIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVOR; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFANT; LONG TERM SURVIVAL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PENIS CANCER; POPULATION RESEARCH; SCHOOL CHILD; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; TONGUE CANCER; TONSIL CANCER; UNITED STATES; UTERINE CERVIX CANCER; VAGINA CANCER; VIRUS LOAD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; SURVIVORS; YOUNG ADULT;

EID: 84881091156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070349     Document Type: Article

References (45)

1. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, et al. (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102: 1083-1095.
2. Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, et al. (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305: 2311-2319.
3. Taylor AJ, Little MP, Winter DL, Sugden E, Ellison DW, et al. (2010) Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 28: 5287-5293.
4. Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, et al. (2009) Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 125: 2400-2405.
5. Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, et al. (2011) Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood 117: 6315-6318.
6. Kenney LB, Yasui Y, Inskip PD, Hammond S, Neglia JP, et al. (2004) Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 141: 590-597.
7. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, et al. (2007) Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 99: 300-308.
8. Inskip PD, Curtis RE, (2007) New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 121: 2233-2240.
9. Robison LL, (2011) Late effects of acute lymphoblastic leukemia therapy in patients diagnosed at 0-20 years of age. Hematology Am Soc Hematol Educ Program 2011: 238-242.
10. Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, et al. (2002) Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 12: 605-611.
11. Erculj N, Faganel Kotnik B, Debeljak M, Jazbec J, Dolzan V, (2012) DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia. J Cancer Res Clin Oncol 138: 1919-1930.
12. Felix CA, Hosler MR, Provisor D, Salhany K, Sexsmith EA, et al. (1996) The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood 87: 4376-4381.
13. Jazbec J, Aplenc R, Dolzan V, Debeljak M, Jereb B, (2003) GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia. Leukemia 17: 2540-2542.
14. Jazbec J, Kitanovski L, Aplenc R, Debeljak M, Dolzan V, (2005) No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia. Leuk Lymphoma 46: 893-897.
15. Mertens AC, Mitby PA, Radloff G, Jones IM, Perentesis J, et al. (2004) XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer 101: 1463-1472.
16. Stanulla M, Loning L, Welte K, Schrappe M, (1999) Secondary brain tumours in children with ALL. Lancet 354: 1126-1127.
17. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, et al. (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57: 684-689.
18. Woo MH, Shuster JJ, Chen C, Bash RO, Behm FG, et al. (2000) Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia 14: 232-237.
19. Yonemoto T, Tatezaki S, Ishii T, Hagiwara Y, Inoue M, (2004) Multiple primary cancers in patients with osteosarcoma: influence of anticancer drugs and genetic factors. Am J Clin Oncol 27: 220-224.
20. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
21. IARC (2007) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses. Lyon: World Health Organization Press.
22. Arbyn M, de Sanjose S, Saraiya M, Sideri M, Palefsky J, et al. (2012) EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 131: 1969-1982.
23. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13: 607-615.
24. Centers for Disease Control and Prevention (2012) Human papillomavirus-associated cancers- United States, 2004-2008. MMWR Morb Mortal Wkly Rep 61: 258-261.
25. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, et al. (2013) Annual Report to the Nation on the Status of Cancer, 1975-2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)-Associated Cancers and HPV Vaccination Coverage Levels. J Natl Cancer Inst.
26. Klosky JL, Howell CR, Li Z, Foster RH, Mertens AC, et al. (2012) Risky health behavior among adolescents in the childhood cancer survivor study cohort. J Pediatr Psychol 37: 634-646.
27. Murphy D, Klosky JL, Termuhlen A, Sawczyn KK, Quinn GP (2012) The need for reproductive and sexual health discussions with adolescent and young adult cancer patients. Contraception.
28. National Cancer Institute Surveillance Epidemiology and End Results Databases. Available: http://seer.cancer.gov/data/seerstat/nov2011/. Accessed: 2012 December 17.
29. Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB, (2012) Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer 36: 183-190.
30. Bleyer A, O'Leary M, Barr R, Ries LAG (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD.
31. United States Department of Health & Human Services Code of Federal Regulations. Title 45 Public Welfare, Part 46: Protection of Human Subjects. Available: http://www.hhs.gov/ohrp/policy/ohrpregulations.pdf. Accessed 2013 January 3.
32. National Cancer Institute Surveillance Epidemiology and End results Site Recode B ICD-O-3 Definition. Available: http://seer.cancer.gov/siterecode_b/icdo3_d12192003/. Accessed 2012 December 17.
33. Lau B, Cole SR, Gange SJ, (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170: 244-256.
34. Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Philadelphia, PA: Lippincott Williams & Wilkins.
35. Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, et al. (2004) Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med 2: 61-70.
36. Yeazel MW, Oeffinger KC, Gurney JG, Mertens AC, Hudson MM, et al. (2004) The cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 100: 631-640.
37. Howlander N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2012) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute.
38. Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB, (2012) Limitations and biases of the Surveillance, Epidemiology, and End Results database. Curr Probl Cancer 36: 216-224.
39. Curtis RE, Ries LAG (2006) Methods. In: Curtis RE, Freedman DM, Ries LAG, Hacker DG, Edwards BK et al., editors. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute.
40. Mertens AC, (2007) Cause of mortality in 5-year survivors of childhood cancer. Pediatr Blood Cancer 48: 723-726.
41. Kovalchik SA, Pfeiffer RM, (2012) Re: Assessment of impact of outmigration on incidence of second primary neoplasms in childhood cancer survivors estimated from SEER data. J Natl Cancer Inst 104: 1517-1518.
42. Sinha P, Logan HL, Mendenhall WM, (2012) Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol 33: 130-136.
43. Jain KS, Sikora AG, Baxi SS, Morris LG (2013) Synchronous cancers in patients with head and neck cancer: Risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer.
44. Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, et al. (2002) Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol 20: 1608-1616.
45. Huang SF, Li HF, Liao CT, Wang HM, Chen IH, et al. (2012) Association of HPV infections with second primary tumors in early-staged oral cavity cancer. Oral Dis 18: 809-815.